In experimental autoimmune encephalomyelitis and a murine model of multiple sclerosis (MS), the inhibition of Ang II signaling reduced the autoreactive T-cell populations while increasing the CD4+ FoxP3+ regulatory T-cells, potentially reversing the disease progression [80,81]. Here, AGT is linked to myeloid sarcoma.